Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Charles University, Czech Republic
ClinicalTrials.gov Identifier:
NCT00430833
First received: January 31, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):